Codexis (CDXS) Total Liabilities (2010 - 2026)
Codexis (CDXS) posted quarterly Total Liabilities of $86.1 million for Q1 2026, up 8.68% year-over-year from $79.3 million in Q1 2025, and down 11.44% quarter-over-quarter from $97.3 million in Q4 2025.
Codexis (CDXS) Total Liabilities (2010 - 2026) Analysis & Trends
Codexis' Total Liabilities history runs 17 years deep, the most recent figure standing at $86.1 million for Q1 2026.
- In Q1 2026, Total Liabilities rose 8.68% year-over-year to $86.1 million; the TTM figure through Mar 2026 stood at $86.1 million (up 8.68% YoY), while the FY2025 annual figure was $97.3 million, up 18.5% from the prior year.
- Total Liabilities for Q1 2026 stood at $86.1 million, down from $97.3 million in the prior quarter.
- The five-year high for Total Liabilities was $105.6 million in Q4 2022, with the low at $49.9 million in Q4 2023.
- The 5-year median for Total Liabilities is $81.2 million (2022), against an average of $79.7 million.
- The sharpest annual moves came in 2023 and 2024: Total Liabilities sank 52.7% in 2023, then surged 64.35% in 2024.
- Codexis' Total Liabilities stood at $105.6 million in 2022, then tumbled by 52.7% to $49.9 million in 2023, then surged by 64.35% to $82.1 million in 2024, then climbed by 18.5% to $97.3 million in 2025, then fell by 11.44% to $86.1 million in 2026.
- Business Quant data shows CDXS's Total Liabilities at $86.1 million in Q1 2026, $97.3 million in Q4 2025, and $85.4 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 7.18 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 10.02 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 1.62 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 4.20 Bn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 4.00 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 4.20 Bn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 3.22 Bn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 1.35 Bn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 10.03 Bn |
| 10 | Codexis | 152.06 Mn | 97.14 Mn | 11.40 Mn | 87.10 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 87.10 Mn |
| Mar 31, 2026 | 86.14 Mn |
| Dec 31, 2025 | 97.27 Mn |
| Sep 30, 2025 | 85.42 Mn |
| Jun 30, 2025 | 82.62 Mn |
| Mar 31, 2025 | 79.26 Mn |
| Dec 31, 2024 | 82.08 Mn |
| Sep 30, 2024 | 74.78 Mn |
| Jun 30, 2024 | 70.56 Mn |
| Mar 31, 2024 | 70.29 Mn |
| Dec 31, 2023 | 49.95 Mn |
| Sep 30, 2023 | 62.95 Mn |
| Jun 30, 2023 | 82.63 Mn |
| Mar 31, 2023 | 92.05 Mn |
| Dec 31, 2022 | 105.60 Mn |
| Sep 30, 2022 | 81.16 Mn |
| Jun 30, 2022 | 75.51 Mn |
| Mar 31, 2022 | 76.64 Mn |
| Dec 31, 2021 | 81.99 Mn |
| Sep 30, 2021 | 58.50 Mn |